We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -11.00 | -0.76% | 1,433.50 | 1,433.00 | 1,433.50 | 1,440.50 | 1,432.00 | 1,439.00 | 277,293 | 09:06:35 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 31.38B | 2.58B | 0.6212 | 23.08 | 59.88B |
From Feb 2020 to Feb 2025
By Cecilia Butini
GlaxoSmithKline PLC on Wednesday posted a slightly declining net profit for the third quarter despite higher sales, and raised its outlook for its 2021 adjusted earnings per share.
The British pharma major said net profit for the period was 1.17 billion pounds ($1.61 billion), slightly down from $1.24 billion the year prior but beating a consensus provided by FactSet which saw the metric at GBP844 million.
Adjusted earnings per share, a closely-watched metric which leaves out some one-off items, came in at 36.6 pence for the period, also beating a FactSet consensus which saw it at 28.63 pence. Adjusted earnings per share in the same quarter the previous year were 35.60 pence.
Sales rose to GBP9.08 billion in the quarter from GBP8.65 billion the previous year, GSK said.
The company raised its outlook on adjusted earnings per share for 2021, saying it now expects the metric to decline between 2% and 4% at constant exchange rates excluding Covid-19 solutions. It had previously foreseen a mid-to-high single-digit decline.
Looking ahead, it reconfirmed the expectation for meaningful improvement in revenues and margin in 2022.
GSK also declared a dividend of 19 pence for the third quarter, continuing to expect 80 pence a share for 2021.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
October 27, 2021 07:38 ET (11:38 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
